First Analysis private equity companies
Below are some of the companies we are helping to build currently and others we have helped build in the past.
- Accellent Corp.
- Achilles Group
- AdvancePath Academics Inc.
- Alien Technology
- American Waste Services Inc.
- ANI Pharmaceuticals Inc.
- Aprimo Inc.
- Aspen Holdings Inc.
- bTrade Inc.
- CCS Medical
- Chrome River
- CiviGenics Inc.
- Community Education Centers Inc.
- Continental Waste Industries
- Correctional Systems Inc.
- Cosmed Group
- CSA Medical
- Cylex Inc.
- Data Critical Corp.
- DataSphere Technologies Inc.
- Dialogic Corp.
- Dynamic Healthcare Tech.
- EDR Inc.
- EraGen Biosciences
- Exodus Communications Inc.
- ExpertPlan Inc.
- Extraprise
- Finjan Inc.
- FutureHealth Corp.
- GAPbuster Worldwide
- GE Wind Energy
- Global Employment Solutions
- GreatFood.com
- Gyrodata Inc.
- IndX Software Corp.
- Initiate Systems
- InPhonic Inc.
- IPLogic
- Kelatron Corp.
- Knowlagent
- KTI Inc.
- Learning.com
- LifeStar Cos.
- M Cubed Technologies Inc.
- Magnify Holdings Corp.
- Matrix Service Co.
- Metalico Inc.
- Movero Inc.
- National Recovery Systems Inc.
- Neptun Light Inc.
- netBOA
- NitroSecurity
- NuCo2 Inc.
- Omnipoint Corp.
- Performance Materials Corp.
- Prosar Corp.
- Pure Cycle Corp.
- QPS Pharmaceutical Services LLC
- ReSearch Pharmaceutical Svcs.
- SDIX
- SeQual Technologies
- Serrot International Inc.
- SmartPros
- Sourcecorp Inc.
- SPI Manufacturing
- SquareTwo Financial
- SterilMed
- TCI Solutions Inc.
- Tetra Technologies Inc.
- The Cobalt Group Inc.
- Ti3 Inc.
- Toplander Corp.
- TransCore
- TransForce Inc.
- Trustwave
- Tut Systems Inc.
- USA Waste Services Inc.
- VPNet Inc.
- Wimba
- Worldprints.com
- Wright Express Corp.
Cylex Inc.
Cylex is a life science diagnostic company and a leader in the development and manufacture of unique products that monitor the immune system for predicting and managing human health. It is the first and only company to offer a patent-protected, FDA-cleared cellular assay of immune system function, ImmuKnow, that measures the vitality of a patient's immune system from a single drop of blood. The company's products enable physicians to better manage and personalize the treatment of organ transplant patients as well as emerging applications across an array of life-threatening diseases, such as HIV, HCV, cancer, diabetes, and autoimmune disorders. Cylex operates in a relatively new segment of diagnostics, measuring specific cellular responses to assess the immune system's health or response to therapy. For example, in transplantation, Cylex’s products allow physicians to monitor patients’ immune system status, providing an additional layer of information to traditional diagnostic measures, such as therapeutic drug levels, cell counts, or the occurrence of negative outcomes such as organ rejection or infection.
Website and contact information: www.cylex.net